Grundinformationen
- Standard-SMILES
CC1=C\[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC\C=C\1- InChIKey
DAIKHDNSXMZDCU-FQTGFAPKSA-N- Summenformel
- C28H35N3O7
- Durchschnittliche Molmasse
- 525,6 g/mol
- Monoisotopische Masse
- 525,24750046
Überblick
Pristinamycin IIA is a macrolide that is (together with pristinamycin IA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus. It has a role as a Mycoplasma genitalium metabolite and an antibacterial drug. It is a secondary carboxamide, a tertiary carboxamide, a pyrroline, a lactam, a macrolide antibiotic, a macrolide, a secondary alcohol, a cyclic ketone, a member of 1,3-oxazoles and an enamide.
Namen und Bezeichner
- Bevorzugter Name
- Virginiamycin M1
- IUPAC
- (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
21411-53-0- PubChem CID
- 5459319
- DTXSID
DTXSID30873800- ChEMBL
CHEMBL1236670- ChEBI
CHEBI:9997- UNII
- 8W4UOL59AZ
- EC Number
- 244-376-6
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,5
- Polarare Oberfläche (TPSA)
- 139 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 8
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 38
- Formalladung
- 0
- Komplexität
- 1.030
Experimentelle und physikochemische Eigenschaften
Chemie und Industrie
Pharmakologische Informationen
Mechanism of Action
Virginiamycin M1 is a macrocyclic lactone antibiotic that acts syngeristically with the structurally unrelated cyclic depsipeptides more commonly known as the virginiamycins B (ostreogrycin B or streptogramin B) and S to inhibit peptide elongation. This is achieved by blocking formation of a peptide bond between the growing peptide chain (peptidyl-tRNA) linked to the 50S ribosome and aminoacyl-tRNA. Virginiamycin M1 has proven to be highly active against Gram positive bacteria, particularly methicillin-resistant S. aureus.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…